EDAP TMS S.A. ADR | Ownership
Companies that own EDAP TMS S.A. ADR
Bruce & Co., Inc.
1,045,494
3.61%
0
0.62%
06/30/2018
Archon Capital Management LLC
736,525
2.54%
-282,486
1.21%
06/30/2018
PSM Vermögensverwaltung GmbH Langen v.d.Goltz, Dr. Prinz
704,718
2.43%
134,438
8.75%
06/29/2018
Manatuck Hill Partners LLC
217,900
0.75%
0
0.23%
06/30/2018
Morgan Stanley & Co. International Plc
76,100
0.26%
15,400
0.01%
06/30/2018
Susquehanna Financial Group LLLP
66,084
0.23%
66,084
0%
06/30/2018
G1 Execution Services LLC
60,149
0.21%
60,149
0.01%
06/30/2018
The California Public Employees Retirement System
42,800
0.15%
0
0%
06/30/2018
Perkins Capital Management, Inc.
25,000
0.09%
-122,000
0.05%
06/30/2018
Geode Capital Management LLC
18,494
0.06%
0
0%
06/30/2018
| Address |
Parc d'Activités la Poudrette-Lamart
Vaulx-en-Velin Rhone-Alpes 69120
France
|
|
Employees
|
- |
| Website |
http://www.edap-tms.com |
| Updated |
07/08/2019 |
| EDAP TMS SA develops, produces and markets minimally invasive medical devices for urological diseases. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. Ablatherm-HIFU is generally recommended for patients with localized prostate cancer who are not candidates for surgery or who prefer an alternative option, or for patients who failed radiotherapy treatment, Ablatherm-HIFU is approved and commercialized in Europe as a treatment for prostate cancer and is currently under regulatory review in the U. |
